Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Lonza Group

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$32M
Portfolio companies 6
Rounds per year 0.06
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Life Science
  • Biopharma
  • Therapeutics
Summary

Lonza Group is the famous Corporate Investor, which was founded in 1897. The main department of described Corporate Investor is located in the Basel. The company was established in Europe in Switzerland.

The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2013. The average startup value when the investment from Lonza Group is 10-50 millions dollars. The usual things for fund are deals in the range of 1 - 5 millions dollars.

Among the various public portfolio startups of the fund, we may underline Odyssey Thera For fund there is no match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Biotechnology, Biopharma. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Lonza Group, startups are often financed by Playground Global. The meaningful sponsors for the fund in investment in the same round are Tandem Capital, Playground Global, HBM Partners.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Atlant Fonder AB Stockholm, Stockholm County, Sweden
Beijing Youqing Yutong Yiliao Touzi Youxian Gongsi Beijing, Beijing, China
Binux Capital California, Saratoga, United States
Boom 22 Blackrock, Dublin, Ireland
Broadridge New York, New York, United States
Diedai Capital China, Hangzhou, Zhejiang
Huatsing Capital Management Co. Ltd. Beijing, Beijing, China
Innovationsstarter Fonds -
Jardine Matheson Group China, Hong Kong, Hong Kong Island
Myer Family Investments Australia, Melbourne, Victoria
Nikkei Digital Media Japan, Tokyo
ODI Startup Accelerator England, London, United Kingdom
Oryzn Capital Israel, Tel Aviv, Tel Aviv
Startech Early Ventures Richardson, Texas, United States
Techbridge International Chelmsford, Massachusetts, United States
Toyoda Gosei Aichi Prefecture, Japan, Kiyosu
Vayner Media New York, New York, United States
Xenon Capital Partners England, London, United Kingdom
Yuantai Investment Partners -
ZSY Capital China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Indapta Therapeutics

Biopharma
Biotechnology
Medical
$50M10 Feb 2022 San Francisco, California, United States

Affinia Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$110M03 May 2021 Massachusetts, United States

Affinia Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$60M31 Mar 2020 Massachusetts, United States

ConnectedYard (pHin)

Consumer Electronics
Service Industry
Water Purification
$7M02 Dec 2016 San Jose, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Lonza Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 32M
Rounds per year 0.06
Peak activity year 2013
Lead investments 0
Follow on index 0.14
Exits 1
Group Appearance index 0.71

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Indapta Therapeutics

Biopharma
Biotechnology
Medical
$50M10 Feb 2022 San Francisco, California, United States

Affinia Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$110M03 May 2021 Massachusetts, United States

Affinia Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$60M31 Mar 2020 Massachusetts, United States

ConnectedYard (pHin)

Consumer Electronics
Service Industry
Water Purification
$7M02 Dec 2016 San Jose, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: